Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • ChatD&B Reviews & Ratings
    Company Website for ChatD&B
  • QUODD Reviews & Ratings
    5.0 out of 5 stars 1 Rating
    Company Website for QUODD
  • D&B Credit Insights Reviews & Ratings
    4.2 out of 5 stars 70 Ratings
    Company Website for D&B Credit Insights
  • Banker's Dashboard Reviews & Ratings
    4.8 out of 5 stars 6 Ratings
    Company Website for Banker's Dashboard
  • DialerAI Reviews & Ratings
    4.8 out of 5 stars 5 Ratings
    Company Website for DialerAI
  • Sumsub Reviews & Ratings
    4.6 out of 5 stars 240 Ratings
    Company Website for Sumsub
  • SurveyLegend Reviews & Ratings
    4.5 out of 5 stars 1,882 Ratings
    Company Website for SurveyLegend
  • Kinderpedia Reviews & Ratings
    4.8 out of 5 stars 322 Ratings
    Company Website for Kinderpedia
  • Wallester Reviews & Ratings
    4.8 out of 5 stars 277 Ratings
    Company Website for Wallester
  • D&B Finance Analytics Reviews & Ratings
    4.2 out of 5 stars 802 Ratings
    Company Website for D&B Finance Analytics

What is EquiReason?

EquiReason is an all-encompassing platform designed for equity research and market insights, aimed at self-directed investors, independent analysts, and research teams. It combines SEC filings, XBRL financial data, earnings-call transcripts, and a wealth of market information to enable users to assess financial performance, ownership patterns, and the broader exposure of companies. The platform diligently monitors market occurrences through economic channels, correlating them with companies that may be affected, and delivers conclusions for each situation, backed by both supporting and opposing arguments. Users are presented with a diverse range of research perspectives, featuring financial statements, insights on valuation, insider and institutional activity, segment revenue information, and company-specific alerts, all linked to their original sources. EquiReason is available through both a web interface and an iPhone application, offering a free tier in addition to various paid research subscriptions to equip users with the necessary resources for informed decision-making. Notably, the platform prioritizes research and decision support over direct investment recommendations, which empowers users to navigate market complexities with enhanced assurance. Furthermore, the user-friendly design ensures that both novice and experienced investors can easily access and interpret the available data.

What is BioSniper?

BioSniper is a research platform specifically designed for equity analysts, investors, and professionals operating within the life sciences industry. It allows users to express their research or investment concepts in clear and simple terms, which the platform then organizes into a structured workflow that incorporates a variety of screenings, evaluations by expert agents, scoring systems, blocking mechanisms, and evidence gates. The platform performs searches across seven distinct categories of public resources, including SEC EDGAR filings, insider trading information, FDA-related events, ClinicalTrials.gov, PubMed, USPTO and Google Patents, biotech news, and market analytics. Findings are meticulously linked to their source records, and any inconsistencies or missing evidence are noted as unknown, avoiding presumptions; it also presents the source and relevant dates when possible. Additionally, BioSniper features a free public calendar for biotech events, an SEC cash runway calculator, and an open-source Python toolkit that users can utilize. Beyond these functionalities, the platform strives to improve the decision-making capabilities of its users by providing extensive access to pertinent data and insights. By continuously evolving, BioSniper positions itself as an indispensable resource for informed decision-making in the dynamic life sciences field.

Media

No images available

Media

No images available

Integrations Supported

Additional information not provided

Integrations Supported

Additional information not provided

API Availability

Has API

API Availability

Pricing Information

$49/month
Free plan available. Analyst is $49/month; Research Pro is $89/month. Annual billing is ten months for twelve. Research Pro has a seven-day trial with no card required.
Free Version
Free Trial Offered?

Pricing Information

$39/month
A free plan is available. Researcher costs $39/month, and Analyst costs $79/month. Monthly AI credit allowances are 200, 3,000, and 10,000 for Free, Researcher, and Analyst, respectively; the plans also differ in research and customization features.
Free Version

Supported Platforms

SaaS
iPhone

Supported Platforms

SaaS

Customer Service / Support

Not specified

Customer Service / Support

Web-Based Support

Training Options

Not specified

Training Options

Documentation Hub

Company Facts

Organization Name

EquiReason

Date Founded

2026

Company Location

Turkey

Company Website

equireason.com

Company Facts

Organization Name

BioSniper

Date Founded

2024

Company Location

United States

Company Website

biosniper.co

Categories and Features

Financial Research

Not specified

Categories and Features

Financial Research

Not specified

Popular Alternatives

Popular Alternatives

Dion Insight Reviews & Ratings

Dion Insight

Dion Global Solutions
Sniper AI Reviews & Ratings

Sniper AI

Recruitment Smart Technologies
VerityRMS Reviews & Ratings

VerityRMS

Verity